Skip to main content

Table 1 Baseline data: participant characteristics, comorbidities and laboratory blood test results

From: Risk factors for foot ulceration in adults with end-stage renal disease on dialysis: study protocol for a prospective observational cohort study

Participants characteristics Comorbidities Laboratory blood test results
Age (years) Diabetes (documented diagnosis in medical history, including type and duration) C-reactive protein (mg/L)
Sex (male or female) Retinopathy (documented diagnosis in medical history) Serum albumin (g/dL)
Height (m) Known peripheral neuropathy (documented diagnosis in medical history) Total calcium (mmol/L)
Weight (kg) Known peripheral arterial disease or history of lower extremity revascularisation procedure (documented diagnosis in medical history or documented lower extremity revascularisation procedure e.g. angioplasty) Serum phosphate (mmol/L)
Parathyroid hormone (pmol/L)
Glycated haemoglobin (%)
Haemoglobin (g/L)
Body mass index (kg/m2) Hypertension (documented diagnosis in medical history and must be requiring medication)  
Smoking history (past, current, never) Dyslipidaemia (documented diagnosis in medical history)
Living arrangements (living alone) Ischaemic heart disease (documented diagnosis of ischaemic heart disease, angina, myocardial infarction or coronary bypass surgery in medical history)
• Indigenous Australian (Aboriginal or Torres Strait Islander)
• English Congestive cardiac failure (documented diagnosis in medical history)
• European
• American
• African Cerebrovascular disease (documented diagnosis of cerebrovascular accident or transient ischaemic attack in medical history)
• Asian
• Pacific Islander
• Other
Cause of end-stage renal disease  
• Diabetic nephropathy Osteoarthritis (documented diagnosis in medical history)
• Hypertensive nephropathy
• Chronic glomerulonephritis Inflammatory arthritis (documented diagnosis in medical history of a type of inflammatory arthritis e.g. gout, rheumatoid arthritis, psoriatic arthropathy)
• Polycystic kidney disease
• Reflux nephropathy
• Renovascular disease
• Vasculitis
• Unknown Other (any other documented medical conditions)
• Other
Dialysis treatment
• Haemodialysis
• Continuous ambulatory peritoneal dialysis
• Automated peritoneal dialysis
Duration of dialysis (months)
  1. An average of the three latest blood test results (i.e. C-reactive protein, serum albumin, total calcium, serum phosphate, parathyroid hormone, glycated haemoglobin and haemoglobin) will be obtained at baseline